Task X9: Agilvax Phage Display for Multiple Vaccine Candidates
$8,224N01FY2023AINIH
Advanced Bioscience Laboratories, Inc., Kensington MD
Investigators
Abstract
This contract provides for manufacturing vaccine and biologic products in accordance with relevant cGMP Phase I/II FDA regulations and guidelines under the NIAID Preclinical Services for Manufacturing and Characterization Services Program.
View original record on NIH RePORTER →